Low-dose Interleukin-2 in the Treatment of Autoimmune Disease | touchONCOLOGY - 0 views
-
affect approximately 5 to 8 % of the US population
-
the incidence and prevalence of autoimmune diseases are rising
-
Type 1 diabetes (T1D), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and inflammatory bowel disease (IBD) account for the majority of the patients with autoimmune diseases
- ...9 more annotations...
-
Great article. Immune dysfunction plays role in autoimmune disease and cancer. Treg cells sit at the center of autoimmunity. This artice highlights the different uses: low dose IL2 therapy to augment Tregs and reduce autoinflammation and high dose IL2 to augment Treg cells in the fight against cancer.
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis - 1 views
-
Padayatty and colleagues showed that high-level ascorbic acid plasma concentrations could only be achieved by intravenous administration
-
No patient in the low or high dose ascorbic acid treatment arms of this study suffered any identifiable adverse event
-
a pharmacologic ascorbic acid treatment strategy in critically ill patients with severe sepsis appears to be safe
- ...7 more annotations...
-
Study finds IV vitamin C in patients with sepsis is very safe and blunts the effects (endothelial damage, end organ damage...) of sepsis. Of note, the IV vitamin C group reached serum levels of ascorbic acid of 1,592 to 5,722 micromol/L. The IV groups maintained elevated serum C levels for up to 96 hours post infusion.
« First
‹ Previous
61 - 80 of 89
Next ›
Showing 20▼ items per page